is the fda banning semaglutide π¨ Moves to Permanently Shut Down Compounded GLP-1s FDA taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these The FDA Is Reconsidering Its
Description
Choose salmon for dinner, then keep the rest of the plate simple

The medication class was not studied extensively in pregnant populations because pregnancy is generally an exclusion criterion in clinical trials

Nutritional deficiencies can develop when appetite suppression leads to inadequate intake of essential nutrients

Why it matters: The growth of weight loss drugs opens the door for wellness and beauty brands created specifically for the side effects some users experience, such as loss in skin elasticity
